Inovio Pharmaceuticals Inc (INO)

Inovio Pharmaceuticals Inc (INO) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	73.57% 0.1027	0.3884	0.226	0.1149	0.1247
Operating Expenses	23.50% 27.50	35.94	37.27	44.07	56.07
Interest Income/Expense	9.94% 0.2823	0.3135	0.3135	0.3135	0.3135
Benefits Costs and Expenses	26.84% 25.11	34.32	35.76	40.76	54.59
Costs And Expenses	26.84% 25.11	34.32	35.76	40.76	54.59
Operating Income/Loss	22.95% -27.39	-35.55	-37.04	-43.95	-55.95
Income/Loss Before Equity Method Investments	26.31% -25.00	-33.93	-35.53	-40.65	-54.46
Income/Loss From Equity Method Investments	-	-	-	-	-
Income/Loss From Continuing Operations Before Tax	26.31% -25.00	-33.93	-35.53	-40.65	-54.46
Income/Loss From Continuing Operations After Tax	26.40% -24.97	-33.93	-35.53	-40.65	-54.46
Net Income/Loss	26.31% -25.00	-33.93	-35.53	-40.65	-54.46
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	189.97% -241.67	268.62	264.35	258.44	3.9875
Diluted Average Shares	189.97% -241.67	268.62	264.35	258.44	3.9875
Basic Earnings Per Share	4,262% -5.67	-0.13	-0.13	-0.16	-0.21
Diluted Earnings Per Share	4,262% -5.67	-0.13	-0.13	-0.16	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-